Cohort studyindependent cross-checkabstract only checked★ key study I-CAN-01 in-depth review

Smokers die about ten years earlier; quitting gives years back

Mortality in relation to smoking: 50 years' observations on male British doctors.

Overview

Doll R et al.. BMJ 2004 · PMID 15213107 · DOI 10.1136/bmj.38142.554479.AE

Smoking tripled death rates; stopping at 30 avoided almost all the excess risk.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Measure smoking hazards over 50 years.

How was the study done?

Prospective cohort.

How many people, animals or samples were studied?

34,439 doctors.

What was actually found?

Smokers die ~10 years earlier.

How large was the observed effect?

3-fold mortality.

What do the results mean in everyday life?

Stopping smoking at any age helps.

What are the study's limitations?

Men only.

What does it say about Elawady's specific claim?

Contradicts smoking dismissal.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Effects of other tobacco products.

Scientific in-depth review

1. Full reference

Authors
Doll R et al.
Journal
BMJ
Year
2004
Identifier
PMID 15213107 DOI 10.1136/bmj.38142.554479.AE
Verification
verified – PubMed esummary + efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Hazards of smoking and benefits of cessation.

3. Study design and population

Study design
Cohort study – Prospective cohort, 50 years
Population

Male British doctors

Country

UK

Period

1951-2001

Sample size

34,439

Inclusion and exclusion criteria

Male doctors responding in 1951

4. Methods and endpoints

Exposure / intervention

Cigarette smoking

Comparator

Lifelong non-smokers; ex-smokers

Endpoints

Cause-specific and overall mortality

Statistical methods

Rate ratios; life expectancy

5. Actual results

Results

Continuing smokers born 1900-1930 died about 10 years younger than lifelong non-smokers; excess deaths chiefly vascular, neoplastic and respiratory. Cessation at 60, 50, 40, 30 gained about 3, 6, 9, 10 years. Among men born around 1920, prolonged smoking tripled age-specific mortality; stopping at 50 halved the hazard, at 30 avoided almost all of it.

Absolute risks

Death in middle age 43% vs 15% (smokers vs non-smokers born in the 1920s)

Authors' conclusion

Prolonged smoking tripled mortality; cessation substantially reduces risk.

6. Strengths

  • 50-year prospective follow-up
  • Repeated exposure assessment

7. Weaknesses

  • Men, doctors only

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

Classic cohort with strong, consistent dose-response.

9. Assessment of the statistical interpretation

Very large effects consistent with causality, replicated worldwide.

10. Relevance to the specific claim

Contradicts dismissal of smoking as a cause of cancer and early death; also shows the body can recover partly after stopping a harmful exposure.

11. Independent contrary findings

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Landmark evidence.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks